1. Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010; 9:941–955.
Article
2. Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013; 5:2502–2521.
Article
3. Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008; 29:726–776.
Article
4. Alsalem JA, Patel D, Susarla R, et al. Characterization of vitamin D production by human ocular barrier cells. Invest Ophthalmol Vis Sci. 2014; 55:2140–2147.
Article
5. Johnson JA, Grande JP, Roche PC, et al. Immuno-localization of the calcitriol receptor, calbindin-d28k and the plasma membrane calcium pump in the human eye. Curr Eye Res. 1995; 14:101–108.
6. Verstappen A, Parmentier M, Chirnoaga M, et al. Vitamin D-dependent calcium binding protein immunoreactivity in human retina. Ophthalmic Res. 1986; 18:209–214.
Article
7. Jones G, Prosser DE, Kaufmann M. Cytochrome p450-mediated metabolism of vitamin D. J Lipid Res. 2014; 55:13–31.
Article
8. Lin Y, Ubels JL, Schotanus MP, et al. Enhancement of vitamin D metabolites in the eye following vitamin D3 supplementation and uv-b irradiation. Curr Eye Res. 2012; 37:871–878.
Article
9. Millen AE, Meyers KJ, Liu Z, et al. Association between vitamin D status and age-related macular degeneration by genetic risk. JAMA Ophthalmol. 2015; 133:1171–1179.
Article
10. Kawasaki R, Yasuda M, Song SJ, et al. The prevalence of age-related macular degeneration in asians: a systematic review and meta-analysis. Ophthalmology. 2010; 117:921–927.
11. Velez-Montoya R, Oliver SC, Olson JL, et al. Current knowledge and trends in age-related macular degeneration: Genetics, epidemiology, and prevention. Retina. 2014; 34:423–441.
12. Parekh N, Chappell RJ, Millen AE, et al. Association between vitamin D and age-related macular degeneration in the third national health and nutrition examination survey, 1988 through 1994. Arch Ophthalmol. 2007; 125:661–669.
Article
13. Lee WJ, Kang MH, Seong M, Cho HY. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion. Br J Ophthalmol. 2012; 96:1426–1430.
Article
14. Kutuzova GD, Gabelt BT, Kiland JA, et al. 1α, 25-Dihydroxyvitamin D (3) and its analog, 2-methylene-19-nor-(20S)-1α, 25-dihydroxyvitamin D (3) (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys. 2012; 518:53–60.
15. Kim EC, Han K, Jee D. Inverse relationship between high blood 25-hydroxyvitamin D and late stage of age-related macular degeneration in a representative korean population. Invest Ophthalmol Vis Sci. 2014; 55:4823–4831.
Article
16. Itty S, Day S, Lyles KW, et al. Vitamin D deficiency in neovascular versus nonneovascular age-related macular degeneration. Retina. 2014; 34:1779–1786.
Article
17. Singh A, Falk MK, Subhi Y, Sørensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One. 2013; 8:e70948.
Article
18. Golan S, Shalev V, Treister G, et al. Reconsidering the connection between vitamin D levels and age-related macular degeneration. Eye (Lond). 2011; 25:1122–1129.
Article
19. Annweiler C, Drouet M, Duval GT, et al. Circulating vitamin D concentration and age-related macular degeneration: systematic review and meta-analysis. Maturitas. 2016; 88:101–112.
Article
20. Wu W, Weng Y, Guo X, et al. The association between serum vitamin D levels and age-related macular degeneration: a systematic meta-analytic review. Invest Ophthalmol Vis Sci. 2016; 57:2168–2177.
Article
21. Cougnard-Gregoire A, Merle BM, Korobelnik JF, et al. Vitamin D deficiency in community-dwelling elderly is not associated with age-related macular degeneration. J Nutr. 2015; 145:1865–1872.
22. Brown CJ, Akaichi F. Vitamin D deficiency and posterior subcapsular cataract. Clin Ophthalmol. 2015; 9:1093–1098.
Article